Live from the NIH registry
Studies recruiting near Lake Charles right now
Top 25 of 27 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Active Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Accurate Clinical Research Inc (SMO/ Network) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Elevara Medicines Limited
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Care Access-Lake Charles, LA — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Systematic Lupus Erythematosus, Cutaneous Lupus Erythematosus
Phase 3
Interventional 202 participants sought
Accurate Clinical Research Inc. - Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: EMD Serono Research & Development Institute, Inc.
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 624 participants sought
GSK Investigational Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: GlaxoSmithKline
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 180 participants sought
Accurate Clinical Research (SMO/Network/Consortium) /ID# 272650 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AbbVie
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Alzheimer Disease, Dementia
Phase 3
Interventional 550 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Sameek Roychowdhury
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 245 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
Influenza
Phase 3
Interventional 10,000 participants sought
Elevate Clinical Research ( Site 0565) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Phase 3
Interventional 600 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
Study of GS-0151 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 1
Interventional 75 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Gilead Sciences
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Plaque Psoriasis
Phase 3
Interventional 3,040 participants sought
Shondra L. Smith, MD - Dermatology and Advanced Aesthetics — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Bristol-Myers Squibb
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 1,196 participants sought
GSK Investigational Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: GlaxoSmithKline
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 320 participants sought
Research Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: AstraZeneca
The RESET System Pivotal Clinical Trial (Protocol Revision K)
Diabetes type2, Obesity
N/A
Interventional 264 participants sought
Elevate Clinical Research, Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Morphic Medical Inc.
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Dogwood Therapeutics Inc.
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 2
Interventional 120 participants sought
Accurate Clinical Research Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Hoffmann-La Roche
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Psoriatic Arthritis
Phase 3
Interventional 1,088 participants sought
Accurate Clinical Research, Inc. | Lake Charles — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Takeda
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Psoriatic Arthritis, Overweight or Obesity
Phase 4
Interventional 200 participants sought
Accurate Clinical Research, Inc — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Obesity, Overweight
Phase 3
Interventional 586 participants sought
Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Eli Lilly and Company
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Lupus Nephritis
Phase 4
Interventional 150 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Aurinia Pharmaceuticals Inc.
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50285 — Lake Charles, Louisiana (0.9 mi)
· Sponsor: UCB Biopharma SRL
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Lake Charles, Louisiana (0.9 mi)
· Sponsor: MoonLake Immunotherapeutics AG
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Phase 3
Interventional 250 participants sought
Accurate Clinical Research, Inc. — Lake Charles, Louisiana (0.9 mi)
· Sponsor: Vor Biopharma